Rowena Dolor Added to PCORI Advisory Panel on Clinical Trials
Rowena Dolor, MD, MHS, has been appointed by the Patient-Centered O
Duke Study Sheds New Light on Statin Therapy for High-Risk Patients
For people who are at high risk for lung cancer— particularly individuals with a longtime smoking history—annual screenings are essential.
CTSI-Backed Startup Gets FDA Clearance for Hernia Mesh Product
A Duke startup, Deep Blue Medical Advances, has received FDA clearance to start selling its patented T-Line® Hernia Mes
MURDOCK C3PI Study on COVID-19 Testing, Serology Underway in Kannapolis
KANNAPOLIS, N.C.—With an enthusiastic response, more than 1,300 people have enrolled in the
Researchers from Duke, UNC, Wake Forest Discuss Research Resilience During COVID-19
On July 9, Duke CTSI partnered with the North Carolina Translational and Clinical Sciences (TraCS) Institute and the Wake Forest Clinical and Translational Science Institute (CTSI) to host “Researc
MEDx Announces COVID-19 Pilot Project Awardees
Medicine + Engineering at Duke (Duke MEDx) has awarded four projects with COVID-19 Pilot Project Awards. To be considered, projects had to involve research that could only be conducted du
Research Resilience in the Age of COVID-19: Insights from Sponsors and Investigators
Thursday, July 9, 2020
2:00-4:30 p.m.